2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)acetonitrile-13CD4; 2,6-Dichloro-?-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile-13CD4; Clinacox-13CD4; Nuoqiu-13CD4; P 64433-13CD4; R 64433-13CD4; Vecoxan
Diclazuril-13C-d4 is a fully characterized chemical compound used as a reference standard of API Diclazuril. The standard offered is compliant with regulatory guidelines. Diclazuril-13C-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
